Johnson and Johnson names Consumer Health Business "Kenvue" Ruchika Sharma29 Sept 2022 3:30 PM ISTKenvue will become a standalone leading global consumer health company in 2023, subject to legal requirements including consultation with works...
Setback to Johnson and Johnson: Maha FDA cancels baby powder manufacturing license Ruchika Sharma17 Sept 2022 11:50 AM ISTFDA issued a show-cause notice to Johnson and Johnson under the Drugs Cosmetics Act 1940 and Rules, besides issuing instructions to the company to...
SII, Aspen Pharmacare join hands to manufacture, sell vaccines in Africa Ruchika Sharma1 Sept 2022 1:13 PM ISTThe deal with Serum gives Aspen certainty on volumes, which will eventually more than cover an expected decline in revenues from its COVID vaccine...
Janssen bags USFDA nod for IMBRUVICA for chronic graft-versus-host disease treatment Ruchika Sharma28 Aug 2022 12:45 PM ISTChronic graft-versus-host disease is a life-threatening complication that can occur after a stem cell or bone marrow transplant when newly...
JnJ to stop manufacturing its talc based baby powder from 2023 Roshni Dhar13 Aug 2022 5:51 PM ISTJohnson & Johnson will stop selling talc-based baby powder globally in 2023, the drug maker said on Thursday, more than two years after it ended...
Health Bulletin 13/August/2022 Roshni Dhar13 Aug 2022 5:20 PM ISTHere are the top health stories for the day:With strict bond terms, Rajasthan in-service PG medicos facing trouble getting study leaveWith the State...
Mired in controversy, JNJ baby powder to go off shelves from 2023 Ruchika Sharma13 Aug 2022 2:00 PM ISTThe company faces about 38,000 lawsuits from consumers and their survivors claiming its talc products caused cancer due to contamination with...
Mathai Mammen leaves position as JnJ Executive Vice President, Pharmaceuticals, RnD Ruchika Sharma12 Aug 2022 3:00 PM ISTNew Brunswick: Johnson & Johnson has announced that Mathai Mammen, M.D., Ph.D., has decided to leave his position as Executive Vice...
Janssen bags USFDA nod for psoriatic arthritis treatment STELARA for pediatric patients Rahul Verma6 Aug 2022 8:16 PM ISTThe Janssen Pharmaceutical Companies of Johnson & Johnson has announced that the U.S. Food and Drug Administration (USFDA) has approved STELARA...
Janssen gets USFDA nod for psoriatic arthritis treatment STELARA for pediatric patients Ruchika Sharma4 Aug 2022 11:46 AM ISTSTELARA is administered as a subcutaneous injection dosed four times per year after two starter doses for the treatment of pediatric patients six...
Johnson and Johnson cancer drug sales help weather hit from stronger dollar Ruchika Sharma20 July 2022 2:00 PM ISTThe company said it was raising prices of some products like painkillers and mouthwash in response to inflation.
Janssen Pharma gets USFDA Breakthrough Therapy Designation for Multiple Myeloma treatment Talquetamab Ruchika Sharma30 Jun 2022 3:02 PM ISTTalquetamab is an investigational, off-the-shelf, T-cell redirecting bispecific antibody targeting both GPRC5D, a novel drug target, on multiple...
